Treatment of MN subgroup incompatibility with intravenous immunoglobulin in a newborn.
Gursoy
Tugba
T
Department of Pediatrics, Neonatology Unit, Hacettepe University Faculty of Medicine, Ankara, Turkey. tugbagursoy@gmail.com
Tekinalp
Gulsevin
G
Yigit
Sule
S
Korkmaz
Ayse
A
Onderoglu
Lutfu
L
D000328:Adult; D001663:Bilirubin / Q000097:blood; D004899:Erythroblastosis, Fetal / Q000097:blood / Q000276:immunology / Q000628:therapy*; D005260:Female; D006801:Humans; D016756:Immunoglobulins, Intravenous / Q000008:administration & dosage*; D007231:Infant, Newborn; D008951:MNSs Blood-Group System / Q000276:immunology*; D008297:Male; D011247:Pregnancy
D016756:Immunoglobulins, Intravenous; D008951:MNSs Blood-Group System; D001663:Bilirubin